PET Imaging

Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.

News

November 25, 2013 — The global market for medical imaging devices is estimated to be at $30.2 billion, forecast to be ...

Time November 25, 2013
arrow
Technology

November 20, 2013 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced that the U.S. Food and Drug ...

Time November 20, 2013
arrow
News

November 8, 2013 — Zevacor Molecular, a healthcare firm that manufactures and distributes positron emissions tomography ...

Time November 08, 2013
arrow
Technology

October 25, 2013 — The U.S. Food and Drug Administration (FDA) today approved Vizamyl (flutemetamol F 18 injection), a ...

Time October 25, 2013
arrow
News

October 22, 2013 – Nuclear Imaging Services LLC (NIS) has completed the first U.S.-based ECAT Scintron installation into ...

Time October 22, 2013
arrow
News

October 10, 2013 — Advanced imaging with Positron Emission Tomography (PET) scans shows promise in predicting which ...

Time October 10, 2013
arrow
Technology

October 7, 2013 — Claron Technology will announce extended modality support for its Nil universal zero-footprint medical ...

Time October 07, 2013
arrow
News

October 3, 2013 — The Alzheimer's Association is disappointed by the Centers for Medicare & Medicaid Services (CMS) ...

Time October 03, 2013
arrow
News

September 6, 2013 — For patients with degenerative cervical myelopathy, imaging with 18F-FDG positron emission ...

Time September 06, 2013
arrow
Feature

July 29, 2013 — GE Healthcare has initiated a Class I recall of most of its SPECT nuclear imaging systems and called for ...

Time July 29, 2013
arrow
Feature | Jamshid Maddahi, M.D., FACC, FASNC, and René R. S. Packard, M.D.

Coronary artery disease (CAD) is a major cause of death in modern industrialized countries. Assessments of regional ...

Time July 26, 2013
arrow
Feature | Nuclear Imaging | Dave Fornell

Just when positron emission tomography (PET) appears to be eclipsing single photon emission computed tomography (SPECT) ...

Time July 23, 2013
arrow
Feature

July 12, 2013 — Biopharmaceuticals Inc. announced the first subject has been enrolled in its NAV4694 global, pivotal ...

Time July 12, 2013
arrow
Feature

July 11, 2013 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Alzheimer Association have ...

Time July 11, 2013
arrow
Videos | Neuro Imaging

Peter Herscovitch, M.D., SNMMI president-elect, explains the advances in molecular imaging for Alzheimer's disease and ...

Time June 24, 2013
arrow
Feature

June 20, 2013 — A relatively new weapon in the fight against childhood brain cancer has emerged that improves upon ...

Time June 20, 2013
arrow
News

June 19, 2013 — Alzheimer’s disease has been linked in many studies to amyloid plaque buildup in the brain, but new ...

Time June 19, 2013
arrow
News

June 19, 2013 — Coronary artery disease (CAD) is one of the world’s most prevalent and silent killers. Positron emission ...

Time June 19, 2013
arrow
News

June 19, 2013 — Researchers have yet again been sent back to the drawing board in the development of the much-sought ...

Time June 19, 2013
arrow
Technology

June 13, 2013 — MIM Software Inc. has introduced a new version of MIM Encore that provides a single platform for viewing ...

Time June 13, 2013
arrow
Subscribe Now